Results 21 to 30 of about 5,828,957 (159)

Post-Finasteride Syndrome: Survey of Dermatologists From the Spanish Hair and Nail Disorders Group

Actas Dermo-Sifiliográficas
Background and objective: Post-finasteride syndrome (PFS) refers to a set of persistent symptoms reported by patients after discontinuation of 5-alpha-reductase inhibitors (5-ARIs).
O.M. Moreno-Arrones, D. Saceda-Corralo, J.L. Gómez-Cano, A. Gómez-Zubiaur, J.M. Mir-Bonafé, C. Serrano-Falcón, G. Garnacho-Saucedo, R. Grimalt, A. Combalia, E. Fernández, S. Vañó-Galván   +10 more
doaj   +2 more sources

The postfinasteride syndrome; an overview [PDF]

Journal of Mind and Medical Sciences, 2016
As a 5-α reductase inhibitor, Finasteride has proven effective in ameliorating two conditions documented to be androgen dependent, namely male androgenic alopecia and benign prostatic hyperplasia. Therapeutic results are maintained as long as the drug is
David L. Rowland, Ion G. Motofei, Florian Popa, Vlad D. Constantin, Adriana Vasilache, Ioana Paunica, Cristian Bălălău, Georgeta P. Păunică, Petrisor Banu, Stana Păunică   +9 more
doaj   +2 more sources

Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024. [PDF]

PLoS ONE
BackgroundFinasteride is commonly utilized in clinical practice for treating androgenetic alopecia, but real-world data regarding the long-term safety of its 0adverse events(AEs) remains incomplete, necessitating ongoing supplementation.
Xiaoling Zhong, Yihan Yang, Sheng Wei, Yuchen Liu   +3 more
doaj   +2 more sources

Post-Finasteride Syndrome or Pre-Existing Vulnerability? Rethinking Patient Selection. [PDF]

J Cosmet Dermatol
Rivetti N.
europepmc   +3 more sources

Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?

, 2018
Sexual dysfunction is a clinical condition due to different causes including the iatrogenic origin. For instance, it is well known that sexual dysfunction may occur in patients treated with antidepressants like selective serotonin reuptake inhibitors (SSRI). A similar side effect has been also reported during treatment with finasteride, an inhibitor of
Giatti, Silvia, Diviccaro, Silvia, Panzica, Giancarlo, Melcangi, Roberto Cosimo   +3 more
openaire   +3 more sources

Pharmacological Management of Pattern Hair Loss

Indian Journal of Plastic Surgery, 2021
Pattern hair loss (PHL) is a condition that worsens with time and the only way it can be slowed down is with pharmacological intervention. Pharmacological treatments for PHL, from an evidenced-based perspective with respect to safety and efficacy, are ...
Sandeep Suresh Sattur, Indu Sandeep Sattur   +1 more
doaj   +1 more source

US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?

European Urology Open Science, 2023
Finasteride competitively inhibits 5α-reductase (5-AR) isoenzymes, which blocks dihydrotestosterone (DHT) production, thereby reducing DHT. Finasteride is used in the management of benign prostatic hyperplasia (BPH) and androgenic alopecia.
Haidar Al Saffar, Jennifer Xu, Jonathan S. O'Brien, Brian D. Kelly, Declan G. Murphy, Nathan Lawrentschuk   +5 more
doaj   +1 more source

Gut Inflammation Induced by Finasteride Withdrawal: Therapeutic Effect of Allopregnanolone in Adult Male Rats

Biomolecules, 2022
The treatment with finasteride (i.e., an inhibitor of 5α-reductase) may be associated with different side effects (i.e., depression, anxiety, cognitive impairment and sexual dysfunction) inducing the so-called post finasteride syndrome (PFS).
Silvia Diviccaro, Silvia Giatti, Lucia Cioffi, Eva Falvo, Monika Herian, Donatella Caruso, Roberto Cosimo Melcangi   +6 more
doaj   +1 more source

Untargeted Metabolomics and Steroid Signatures in Urine of Male Pattern Baldness Patients after Finasteride Treatment for a Year

Metabolites, 2020
Male pattern baldness (MPB) has been associated with dihydrotestosterone (DHT) expression. Finasteride treats MPB by inhibiting 5-alpha reductase and blocking DHT production.
Yu Ra Lee, Eunju Im, Haksoon Kim, Bark Lynn Lew, Woo-Young Sim, Jeongae Lee, Han Bin Oh, Ki Jung Paeng, Jongki Hong, Bong Chul Chung   +9 more
doaj   +1 more source

Persistent Sexual, Emotional, and Cognitive Impairment Post-Finasteride

American Journal of Men's Health, 2015
Finasteride is a synthetic 5-α reductase inhibitor, which prevents the conversion of testosterone to dihydrotestosterone and has been used for more than 20 years in the treatment of male pattern hair loss.
Christine Anne Ganzer PhD, Alan Roy Jacobs MD, Farin Iqbal   +2 more
doaj   +1 more source